David Michael Grossman - Stifel, Nicolaus & Company, Incorporated, Research Division

George Robert Hill - Deutsche Bank AG, Research Division

Johnathan M. McCary - Raymond James & Associates, Inc., Research Division

Joseph D. Vruwink - Robert W. Baird & Co. Incorporated, Research Division

Yeo-Jin Lee - BofA Securities, Research Division

Welcome to Definitive Healthcare's Q2 2025 Earnings Call. Later, we will conduct a question-and-answer session. I would now like to turn the call over to your host. You may begin.

Jonathan Paris

Good afternoon. Thank you for joining us today to review Definitive Healthcare's financial results. Joining me on the call today are Kevin Coop, Chief Executive Officer; and Casey Heller, Chief Financial Officer.

During this call, we will make forward-looking statements, including, but not limited to, statements related to our market and future performance and growth opportunities, the benefits of our differentiated data and health care commercial intelligence solutions, our competitive position, customer behaviors and use of our solutions, customer growth, renewals and retention, our financial guidance our planned investments and operational strategy, generating value for our customers and shareholders. The anticipated impacts of global macroeconomic conditions on our business results and customers and on the health care industry generally and our ability to successfully transition executive leadership.

Any forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve a number of risks and uncertainties, including those discussed in the Risk Factors section and elsewhere in our filings with the SEC. Actual results may differ materially from any forward-looking statements.